RN Mobile Menu

Search form


American College of Rheumatology (ACR) 2016 annual meeting

ACR 2016 Annual Meeting

The annual meeting of the American College of Rheumatology begins Nov. 11 in Washington, D.C. Rheumatology Network will highlight selected presentations and post news summaries on our conference page live throughout the meeting.
(U.S. Capitol, Pennsylvania Avenue ©OrhanCamShutterstock.com)

American College of Rheumatology (ACR) 2016 annual meeting

In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.

Good early management of pulmonary hypertension in patients with systemic sclerosis leads to better outcomes and fewer complications, researchers report.

Circulating IgG4/IgG ASC percentages of greater than five percent are a more sensitive and reliable marker for disease activity in patients with IgG4-RD, researchers report.

Systemic sclerosis patients with pulmonary hypertension and heart dysfunction are more likely to succumb from scleroderma-related causes, researchers report.

Redefining disease remission or inactivity examined in this assessment by Laura Coates of the University of Leeds.

Patients with systemic lupus erythematosus have a 38 percent higher adjusted risk of stroke, shows a Harvard study presented at ACR 2016.

One in three U.S. adults with arthritis are prescribed opioids, which vary by mortality risk and effectiveness, researchers recently reported at ACR 2016.


Subscribe to American College of Rheumatology (ACR) 2016 annual meeting on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.